Metabolic abnormalities associated with elevated serum cystatin C in adults with an estimated GFR ≥ 60 ml/min/1.73m 2

Elevated serum cystatin C may represent an early stage of kidney disease. It is unclear whether metabolic abnormalities typically seen in advanced chronic kidney disease are present in adults with estimated glomerular filtration rate ≥ 60 ml/min/1.73m 2 and elevated cystatin C. Participants of the Third National Health and Nutrition Examination Survey (n=6722) were categorized into three groups: estimated glomerular filtration rate ≥ 60 ml/min/1.73m 2 and cystatin C <1.09 mg/L (normal cystatin C); estimated glomerular filtration rate ≥ 60 ml/min/1.73m 2 and cystatin C ≥ 1.09 mg/L (elevated cystatin C); and estimated glomerular filtration rate of 15-59 ml/min/1.73m 2 (stage 3 or 4 chronic kidney disease). Among those with normal cystatin C, elevated cystatin C, and stage 3 or 4 chronic kidney disease, the age, race-ethnicity, sex standardized prevalence of serum hemoglobin <12 g/dL (<13 g/dL for men) was 4.3%, 8.2%, and 13.8%; serum uric acid ≥ 5.9 mg/ dL ( ≥ 7.4 mg/dL for

[1]  Devin Mann,et al.  Overweight, obesity, and elevated serum cystatin C levels in adults in the United States. , 2008, The American journal of medicine.

[2]  C. Schmid,et al.  Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[3]  A. Köttgen,et al.  Serum cystatin C in the United States: the Third National Health and Nutrition Examination Survey (NHANES III). , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[4]  J. Griffith,et al.  The relationship between nontraditional risk factors and outcomes in individuals with stage 3 to 4 CKD. , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[5]  J. Kaufman,et al.  Age affects outcomes in chronic kidney disease. , 2007, Journal of the American Society of Nephrology : JASN.

[6]  N. Cook Use and Misuse of the Receiver Operating Characteristic Curve in Risk Prediction , 2007, Circulation.

[7]  Samuele M. Marcora,et al.  GFR estimation using cystatin C is not independent of body composition. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[8]  L. Stevens,et al.  Serum cystatin C as a marker of glomerular filtration rate , 2006, Current opinion in nephrology and hypertension.

[9]  B. Kestenbaum,et al.  Cystatin C and Prognosis for Cardiovascular and Kidney Outcomes in Elderly Persons without Chronic Kidney Disease , 2006, Annals of Internal Medicine.

[10]  Tom Greene,et al.  Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate , 2006, Annals of Internal Medicine.

[11]  Tom Greene,et al.  Assessing kidney function--measured and estimated glomerular filtration rate. , 2006, The New England journal of medicine.

[12]  K. Mehta,et al.  Mortality risk stratification in chronic kidney disease: one size for all ages? , 2006, Journal of the American Society of Nephrology : JASN.

[13]  T. Larson,et al.  Glomerular filtration rate estimated by cystatin C among different clinical presentations. , 2006, Kidney international.

[14]  S. Cummings,et al.  Cystatin C and mortality risk in the elderly: the health, aging, and body composition study. , 2005, Journal of the American Society of Nephrology : JASN.

[15]  D. Siscovick,et al.  Cystatin C and the risk of death and cardiovascular events among elderly persons. , 2005, The New England journal of medicine.

[16]  J. Manson,et al.  A Randomized Trial of Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease in Women , 2005, The New England journal of medicine.

[17]  A. Folsom,et al.  Traditional and nontraditional risk factors predict coronary heart disease in chronic kidney disease: results from the atherosclerosis risk in communities study. , 2005, Journal of the American Society of Nephrology : JASN.

[18]  M. Pepe,et al.  Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. , 2004, American journal of epidemiology.

[19]  D. Spiegelman,et al.  Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. , 2004, Kidney international.

[20]  B. Astor,et al.  Prevalence of acidosis and inflammation and their association with low serum albumin in chronic kidney disease. , 2004, Kidney international.

[21]  N. Powe,et al.  Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition. , 2004, JAMA.

[22]  P. Whelton,et al.  The Prevalence of Nontraditional Risk Factors for Coronary Heart Disease in Patients with Chronic Kidney Disease , 2004, Annals of Internal Medicine.

[23]  G. Spinas,et al.  Serum cystatin C is sensitive to small changes in thyroid function. , 2003, Clinica chimica acta; international journal of clinical chemistry.

[24]  C. Zoccali,et al.  Fibrinogen, mortality and incident cardiovascular complications in end‐stage renal failure , 2003, Journal of internal medicine.

[25]  G. Chertow,et al.  Elevations of serum phosphorus and potassium in mild to moderate chronic renal insufficiency. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[26]  V. Dharnidharka,et al.  Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[27]  B. Astor,et al.  Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988-1994). , 2002, Archives of internal medicine.

[28]  Tom Greene,et al.  Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[29]  C. Price,et al.  Cystatin C: an improved estimator of glomerular filtration rate? , 2002, Clinical chemistry.

[30]  J. Kos,et al.  Serum cystatin C, a potent inhibitor of cysteine proteinases, is elevated in asthmatic patients. , 2000, Clinica chimica acta; international journal of clinical chemistry.

[31]  I. Rosenberg,et al.  Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients. A prospective study. , 1997, Arteriosclerosis, thrombosis, and vascular biology.